作者
David F Boyd, E Kaitlynn Allen, Adrienne G Randolph, Xi-zhi J Guo, Yunceng Weng, Catherine J Sanders, Resha Bajracharya, Natalie K Lee, Clifford S Guy, Peter Vogel, Wenda Guan, Yimin Li, Xiaoqing Liu, Tanya Novak, Margaret M Newhams, Thomas P Fabrizio, Nicholas Wohlgemuth, Peter M Mourani, Thomas N Wight, Stacey Schultz-Cherry, Stephania A Cormier, Kathryn Shaw-Saliba, Andrew Pekosz, Richard E Rothman, Kuan-Fu Chen, Zifeng Yang, Richard J Webby, Nanshan Zhong, Jeremy Chase Crawford, Paul G Thomas
发表日期
2020/11/19
期刊
Nature
卷号
587
期号
7834
页码范围
466-471
出版商
Nature Publishing Group UK
简介
Severe respiratory infections can result in acute respiratory distress syndrome (ARDS). There are no effective pharmacological therapies that have been shown to improve outcomes for patients with ARDS. Although the host inflammatory response limits spread of and eventually clears the pathogen, immunopathology is a major contributor to tissue damage and ARDS,. Here we demonstrate that respiratory viral infection induces distinct fibroblast activation states, which we term extracellular matrix (ECM)-synthesizing, damage-responsive and interferon-responsive states. We provide evidence that excess activity of damage-responsive lung fibroblasts drives lethal immunopathology during severe influenza virus infection. By producing ECM-remodelling enzymes—in particular the ECM protease ADAMTS4—and inflammatory cytokines, damage-responsive fibroblasts modify the lung microenvironment to promote …
引用总数
2019202020212022202320241234353816
学术搜索中的文章